Literature DB >> 16188464

Epilepsy in the UK: misdiagnosis, mistreatment, and undertreatment? The Wrexham area epilepsy project.

J P Leach1, R Lauder, A Nicolson, D F Smith.   

Abstract

OBJECTIVE: To assess the diagnostic and therapeutic difficulties in patients with epilepsy who had never come into contact with specialist services.
METHODS: Assessment was offered to 676 patients diagnosed as having epilepsy and receiving anti-epileptic drug therapy (AED), who had no previous contact with the local epilepsy services. Two hundred and seventy-five patients gave consent and attended for reassessment. We identified the proportion of patients (a) who had previously seen a neurologist, (b) in whom the diagnosis of epilepsy was not secure, (c) in whom planned AED withdrawal could be considered (d) in whom seizure control could be improved.
RESULTS: 53/275 (19.3%) of those attending for review had previously been seen by a neurologist. 87/275 (31.6%) patients ultimately received continued specialist care. Diagnostic doubt was expressed in 3/53 (5.6%) and 42/222 (18.9%) of patients diagnosed by neurologist and non-specialist, respectively. Of 133/219 (60.7%) of patients whose epilepsy was in remission, only 6 elected to withdraw or change medication. Of 18 patients with diagnostic doubt who accepted follow-up, 12 successfully stopped treatment. 17/55 (30.9%) patients with active epilepsy (10 partial, 7 generalised) achieved at least a 1 year remission consequent upon treatment in this clinic. In 15 cases this was a first ever remission.
CONCLUSION: Approximately 55% of the population of adults receiving treatment for epilepsy have never received specialist advice. Reassessment of these patients uncovers diagnostic uncertainty, failure to classify (leading to sub-optimal therapy) and lack of information and advice about all aspects of epilepsy care. The development of integrated services for people with epilepsy (PWE) must take account of this hidden need. The new General Medical Services contract for general practitioners will bring this need to our attention, and our experience will help predict the measures required to deal with the under-treatent and mistreatment of this group. The majority of PWE, not currently receiving shared care, merit reassessment and approximately one-third will require continued specialist care. Existing services do not have the capacity to process a marked increase in rate of referral. This project informs prioritisation of referrals and service reorganisation.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16188464     DOI: 10.1016/j.seizure.2005.08.008

Source DB:  PubMed          Journal:  Seizure        ISSN: 1059-1311            Impact factor:   3.184


  13 in total

1.  Medicine and the media: the ethics of virtual medical encounters.

Authors:  Alistair Wardrope; Markus Reuber
Journal:  Clin Med (Lond)       Date:  2019-01       Impact factor: 2.659

Review 2.  Pharmacoresistance and the role of surgery in difficult to treat epilepsy.

Authors:  Samuel Wiebe; Nathalie Jette
Journal:  Nat Rev Neurol       Date:  2012-09-11       Impact factor: 42.937

3.  Seizures as the first clinical manifestation of acute pulmonary embolism: an underestimate issue in neurocritical care.

Authors:  Marco Zuin; Gianluca Rigatelli; Giovanni Zuliani; Alessandro Adami; Pietro Zonzin; Loris Roncon
Journal:  Neurol Sci       Date:  2020-02-10       Impact factor: 3.307

4.  Value of patient-reported symptoms in the diagnosis of transient loss of consciousness.

Authors:  Markus Reuber; Min Chen; Jenny Jamnadas-Khoda; Mark Broadhurst; Melanie Wall; Richard A Grünewald; Stephen J Howell; Matthias Koepp; Steve Parry; Sanjay Sisodiya; Matthew Walker; Dale Hesdorffer
Journal:  Neurology       Date:  2016-07-06       Impact factor: 9.910

5.  Machine learning as a diagnostic decision aid for patients with transient loss of consciousness.

Authors:  Alistair Wardrope; Jenny Jamnadas-Khoda; Mark Broadhurst; Richard A Grünewald; Timothy J Heaton; Stephen J Howell; Matthias Koepp; Steve W Parry; Sanjay Sisodiya; Matthew C Walker; Markus Reuber
Journal:  Neurol Clin Pract       Date:  2020-04

6.  Limited care offered to people with epilepsy in Mwanza, Tanzania: need for intervention.

Authors:  Haruna Dika; Rahel Nkola; Shabani Iddi; Catherine Magwiza; Gilbert Kongola
Journal:  Pan Afr Med J       Date:  2021-04-29

7.  Attitudes of US medical trainees towards neurology education: "Neurophobia" - a global issue.

Authors:  Andrey V Zinchuk; Eoin P Flanagan; Niall J Tubridy; Wendy A Miller; Louise D McCullough
Journal:  BMC Med Educ       Date:  2010-06-23       Impact factor: 2.463

Review 8.  Managing drug-resistant epilepsy: challenges and solutions.

Authors:  Linda Dalic; Mark J Cook
Journal:  Neuropsychiatr Dis Treat       Date:  2016-10-12       Impact factor: 2.570

9.  Syncope and Epilepsy coexist in 'possible' and 'drug-resistant' epilepsy (Overlap between Epilepsy and Syncope Study - OESYS).

Authors:  Andrea Ungar; Alice Ceccofiglio; Francesca Pescini; Chiara Mussi; Gianni Tava; Martina Rafanelli; Assunta Langellotto; Niccolò Marchionni; J Gert van Dijk; Gianlugi Galizia; Domenico Bonaduce; Pasquale Abete
Journal:  BMC Neurol       Date:  2017-02-28       Impact factor: 2.474

10.  Can Assessment of the Tongue on Brain MRI Aid Differentiation of Seizure from Alternative Causes of Transient Loss of Consciousness?

Authors:  J A Erickson; M D Benayoun; C M Lack; J R Sachs; P M Bunch
Journal:  AJNR Am J Neuroradiol       Date:  2021-06-11       Impact factor: 4.966

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.